ELAVL4-AS1

Across TCGA pan-cancer cohorts, ELAVL4-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated ELAVL4-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ELAVL4-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ELAVL4-AS1 expression acts as an unfavorable survival marker, although some lineages such as PAAD and PCPG show a favorable association.

KIRC, THCA, and KIRP are the cancer types where ELAVL4-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.360	0.685	<.001	105	view →
THCA	DFS	Tertile	All	0.214	0.847	<.001	75	view →
KIRP	OS	Tertile	II,III,IV	0.384	0.758	.002	54	view →
CHOL	OS	Quartile	II,III,IV	0.151	0.757	.003	32	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	27	view →
PAAD	DFS	Tertile	All	0.586	0.256	.022	24	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	24	view →
THYM	DFS	Tertile	II,III,IV	0.255	0.771	.010	18	view →
STAD	DFS	Tertile	All	0.572	0.746	.026	18	view →
PCPG	DFS	Tertile	All	0.960	0.774	.003	12	view →
TGCT	DFS	Tertile	All	0.502	0.709	.028	12	view →
SKCM	OS	Tertile	All	0.187	0.352	.021	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

ELAVL4-AS1–KIRC (DFS)

Open the KIRC breakdown →